Cross Country Valuation

CCRN Stock  USD 8.70  0.07  0.80%   
At this time, the firm appears to be undervalued. Cross Country Healthcare shows a prevailing Real Value of $9.33 per share. The current price of the firm is $8.7. Our model approximates the value of Cross Country Healthcare from analyzing the firm fundamentals such as Return On Equity of -0.0377, profit margin of (0.01) %, and Current Valuation of 188.08 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cross Country's valuation include:
Price Book
0.6983
Enterprise Value
188.1 M
Enterprise Value Ebitda
55.6625
Price Sales
0.2528
Forward PE
35.461
Undervalued
Today
8.70
Please note that Cross Country's price fluctuation is somewhat reliable at this time. Calculation of the real value of Cross Country Healthcare is based on 3 months time horizon. Increasing Cross Country's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cross Country is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cross Stock. However, Cross Country's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  8.7 Real  9.33 Target  9.93 Hype  8.63 Naive  9.28
The intrinsic value of Cross Country's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cross Country's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
9.33
Real Value
12.84
Upside
Estimating the potential upside or downside of Cross Country Healthcare helps investors to forecast how Cross stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cross Country more accurately as focusing exclusively on Cross Country's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.010.020.08
Details
Hype
Prediction
LowEstimatedHigh
5.128.6312.14
Details
Naive
Forecast
LowNext ValueHigh
5.769.2812.79
Details
7 Analysts
Consensus
LowTarget PriceHigh
9.049.9311.02
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cross Country's intrinsic value based on its ongoing forecasts of Cross Country's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cross Country's closest peers.

Cross Country Cash

98.57 Million

Cross Country Total Value Analysis

Cross Country Healthcare is currently projected to have valuation of 188.08 M with market capitalization of 285.01 M, debt of 3.87 M, and cash on hands of 279 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cross Country fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
188.08 M
285.01 M
3.87 M
279 K

Cross Country Investor Information

About 85.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.7. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cross Country Healthcare recorded a loss per share of 0.49. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Cross Country's financial statements, Cross Country Healthcare is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Cross Country Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Cross suggests not a very effective usage of assets in March.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Cross Country Profitability Analysis

Based on the key profitability measurements obtained from Cross Country's financial statements, Cross Country Healthcare may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess Cross Country's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-6.7 M
Current Value
-4.8 M
Quarterly Volatility
22.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
As of the 1st of March 2026, Gross Profit Margin is likely to grow to 0.28, while Gross Profit is likely to drop about 220 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.280.23
Fairly Up
Slightly volatile
For Cross Country profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cross Country Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cross Country utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cross Country's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cross Country over time as well as its relative position and ranking within its peers.

Cross Country Earnings per Share Projection vs Actual

By analyzing Cross Country's earnings estimates, investors can diagnose different trends across Cross Country's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cross Country Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Cross Country is projected to generate 0.02345 in earnings per share on the 31st of December 2026. Cross Country earnings estimates show analyst consensus about projected Cross Country EPS (Earning Per Share). It derives the highest and the lowest estimates based on Cross Country's historical volatility. Many public companies, such as Cross Country, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Cross Country Ownership Allocation

Cross Country holds a total of 32.76 Million outstanding shares. The majority of Cross Country Healthcare outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cross Country Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cross Country. Please pay attention to any change in the institutional holdings of Cross Country Healthcare as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Cross Country Profitability Analysis

The company reported the previous year's revenue of 1.34 B. Net Loss for the year was (14.56 M) with profit before overhead, payroll, taxes, and interest of 227.58 M.

About Cross Country Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cross Country Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cross Country Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Cross Country's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cross Country's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cross Country. We calculate exposure to Cross Country's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cross Country's related companies.
Last ReportedProjected for Next Year
Gross Profit315.4 M220 M
Pretax Profit Margin(0.01)(0.01)
Operating Profit Margin(0.01)(0.01)
Net Loss(0.01)(0.01)
Gross Profit Margin 0.23  0.28 

Cross Country Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding33.4 M
Quarterly Earnings Growth Y O Y-0.785
Forward Price Earnings35.461

Cross Country Current Valuation Indicators

Cross Country's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cross Country's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cross Country, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cross Country's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cross Country's worth.
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Health Care Providers & Services sector continue expanding? Could Cross diversify its offerings? Factors like these will boost the valuation of Cross Country. Projected growth potential of Cross fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cross Country data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.79)
Earnings Share
(0.49)
Revenue Per Share
34.789
Quarterly Revenue Growth
(0.21)
Return On Assets
0.0048
Understanding Cross Country Healthcare requires distinguishing between market price and book value, where the latter reflects Cross's accounting equity. The concept of intrinsic value - what Cross Country's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Cross Country's price substantially above or below its fundamental value.
It's important to distinguish between Cross Country's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cross Country should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cross Country's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.